Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07457008) titled 'Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: West China Second University Hospital

Condition: Healthy Volunteers

Intervention: Drug: The 10mg dose group Drug: The 20mg dose group Drug: The 30mg dose group

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: July 1, 20...